17 May 2024 Blog How to be clear about royalty payments in a pharmaceutical licensing transaction A recent Court of Appeal case looks at how to draft royalty clauses in a pharmaceutical patent licence, where claim scope and validity may be uncertain, and the product at an early stage of development. Share this article Bookmark this page 4 min read
10 May 2024 Blog MHRA issues its first medicinal product approval through the International Recognition Procedure The MHRA has promised a pro-innovation agenda for life sciences. The first approval of a medicinal product through the International Recognition Procedure is a welcome step for industry and patients alike. Share this article Bookmark this page 2 min read
26 February 2024 Insight Making the most of a better climate – biotech M&A in 2024 M&A transactions entered a period of unprecedented activity in 2021. As the era of uncertainty caused by the pandemic started to ease, deal volume and values exceeded expectations across the globe. Bookmark this page 5 min read
13 February 2024 Blog Disparaging the competition? Recent competition law investigations in the life sciences sector highlight the need for caution when making statements about a competitor's products. Share this article Bookmark this page 3 min read
A sense of direction for AI Artificial intelligence is bringing amazing advances to our world, particularly to the health and care sector. But, is it time for global, joined-up regulation? Read our research report conducted with AMRC. A sense of direction for AI
Environmental, Social and Governance (ESG) We help you keep pace with the changes, challenges and opportunities in this rapidly evolving landscape. Read more about ESG